A high-throughput fluorescence polarization anisotropy assay for the 70N domain of replication protein A

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Analytical Biochemistry (Impact Factor: 2.31). 12/2011; 421(2):742-9. DOI: 10.1016/j.ab.2011.11.025
Source: PubMed

ABSTRACT Replication protein A (RPA) interacts with multiple checkpoint proteins and promotes signaling through the ATR kinase, a key regulator of checkpoint pathways in the mammalian response to DNA damage. In cancer cells, increased DNA repair activity contributes to resistance to chemotherapy. Therefore, small molecules that block binding of checkpoint proteins to RPA may inhibit the DNA damage response and, thus, sensitize cancer cells to DNA-damaging agents. Here we report on the development of a homogeneous, high-throughput fluorescence polarization assay for identifying compounds that block the critical protein-protein interaction site in the basic cleft of the 70N domain of RPA (RPA70N). A fluorescein isothiocyanate (FITC)-labeled peptide derived from the ATR cofactor, ATRIP, was used as a probe in the binding assay. The ability of the assay to accurately detect relevant ligands was confirmed using peptides derived from ATRIP, RAD9, MRE11, and p53. The assay was validated for use in high-throughput screening using the Spectrum collection of 2000 compounds. The FPA assay was performed with a Z' factor of ≥ 0.76 in a 384-well format and identified several compounds capable of inhibiting the RPA70N binding interface.


Available from: Elaine Maria Souza-Fagundes, Jun 06, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The selection of natural and chemical compounds for potential applications in new pharmaceutical formulations constitutes a time-consuming procedure in drug screening. To overcome this issue, new devices called biosensors, have already demonstrated their versatility and capacity for routine clinical diagnosis. Designed to perform analytical analysis for the detection of a particular analyte, biosensors based on the coupling of proteins to amperometric and optical devices have shown the appropriate selectivity, sensibility and accuracy. During the last years, the exponential demand for pharmacokinetic studies in the early phases of drug development, along with the need of lower molecular weight detection, have led to new biosensor structure materials with innovative immobilization strategies. The result has been the development of smaller, more reproducible biosensors with lower detection limits, and with a drastic reduction in the required sample volumes. Therefore in order to describe the main achievements in biosensor fields, the present review has the main aim of summarizing the essential strategies used to generate these specific devices, that can provide, under physiological conditions, a credible molecule profile and assess specific pharmacokinetic parameters.
    Molecules 08/2014; 19(8):12461-12485. DOI:10.3390/molecules190812461 · 2.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Replication Protein A is the primary eukaryotic ssDNA binding protein that has a central role in initiating the cellular response to DNA damage. RPA recruits multiple proteins to sites of DNA damage via the N-terminal domain of the 70 kDa subunit (RPA70N). Here we describe the optimization of a diphenylpyrazole carboxylic acid series of inhibitors of these RPA-protein interactions. We evaluated substituents on the aromatic rings as well as the type and geometry of the linkers used to combine fragments, ultimately leading to submicromolar inhibitors of RPA70N protein-protein interactions.
    ACS Medicinal Chemistry Letters 02/2015; 6(2):140-5. DOI:10.1021/ml5003629 · 3.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fluorescence anisotropy (FA) has attracted a lot of attentions, but it has been scarely applied for the detection of small molecules and metal ions because they are too small to induce obvious FA changes. Although some mass amplifying strategies have been developed, the recognition probes need to be covalently modified with the fluorescent dyes, which is complex and expensive. To overcome this limitation, a new simple, label-free and cost-effective method for the sensitive detection of potassium ion (K+) by using graphene oxide (GO) as FA enhancer, a G-rich single stranded DNA (ssDNA) as recognition probe and acidine orange (AO) as FA reporting fluorophore was established in this paper. In the absence of K+, both ssDNA and AO are adsorbed on the surface of GO, and the FA of AO is enhanced greatly because the rotation of AO is coupled with the entire formation. After the addition of K+, the ssDNA self-associates into the G-quadruplex srtucture. Then AO can bind with the formed G-quadruplex strongly, keeping away from the surface of GO, and the FA of AO decreases significantly because of the relatively small size of the complex of AO and G-quadruplex. Thus K+ can be detected sensitively in the range of 10 μM-2 mM based on the obviously decreased FA. This method is a further improvement of the previous reported mass amplifying strategies because it does not require any covalent labelling of the recognition probe, and it can be potentially applied for detection of a variety of other targets.
    The Analyst 10/2014; 140(1). DOI:10.1039/C4AN01433B · 3.91 Impact Factor